Replimune (REPL) has announced that it has no other option but to reduce its workforce and scale back U.S. manufacturing operations after the FDA on Friday declined to approve its lead asset, RP1, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

After initially setting out plans to lay off dozens of workers in Massachusetts, Replimune Group is now increasing those ...

In April 2026, Replimune Group received a complete response letter from the FDA for its BLA seeking approval of RP1 plus nivolumab for advanced melanoma, despite earlier breakthrough therapy ...

The terminal is fine. But if you actually want to live in your Hermes agent, here are the four best GUIs the community has ...

・The FDA previously rejected approval for RP1 in July. ・The agency noted that the members of the team who reviewed the resubmission were different from those who reviewed the initial application to ...

LofyGang resurfaces with LofyStealer disguised as Minecraft hack, exfiltrating IBANs and passwords to 24.152.36[.]241, ...

Anthropic is no longer offering a free ride for third-party apps using its Claude AI. Boris Cherny, Anthropic's creator and head of Claude Code, posted on X that Claude subscriptions will no longer ...

The U.K. government underlined its previous stance that the United States could only use British bases for defensive purposes, after President Trump threatened to strike civilian targets. By Michael D ...

There’s a right way, and a wrong way. Don’t choose the wrong way. Like many, I’ve never met a chatbot I trust completely. Not ...

Programmers learning Rust struggle to understand own\x02ership types, Rust’s core mechanism for ensuring memory safety ...

Replimune’s RP1 is based on a genetically engineered herpes simplex virus intended to stimulate an anti-tumour immune response.